{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:37:38Z","timestamp":1791293858448,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.physbeh.2012.03.004","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T12:46:32Z","timestamp":1331383592000},"page":"699-710","source":"Crossref","is-referenced-by-count":142,"title":["Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y"],"prefix":"10.1016","volume":"107","author":[{"given":"Mallory E.","family":"Bowers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J.","family":"Ressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2012.03.004_bb0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1176\/appi.ajp.2009.09071074","article-title":"How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD","volume":"167","author":"Jovanovic","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0010","doi-asserted-by":"crossref","first-page":"14993","DOI":"10.1523\/JNEUROSCI.4268-10.2010","article-title":"Erasing fear memories with extinction training","volume":"30","author":"Quirk","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.conb.2011.04.003","article-title":"Hippocampal regulation of aversive memories","volume":"21","author":"Goosens","year":"2011","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.biopsych.2006.03.010","article-title":"Prefrontal mechanisms in extinction of conditioned fear","volume":"60","author":"Quirk","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/syn.10279","article-title":"Differential projections of the infralimbic and prelimbic cortex in the rat","volume":"51","author":"Vertes","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.mp.4001939","article-title":"Mechanisms of fear extinction","volume":"12","author":"Myers","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.bmb.a071781","article-title":"Opioid Peptides: introduction","volume":"39","author":"Hughes","year":"1983","journal-title":"Br Med Bull"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0040","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1037\/h0077609","article-title":"Naloxone and shock-elicited freezing in the rat","volume":"93","author":"Fanselow","year":"1979","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0050","series-title":"Paper presented at the meeting of the Eastern Psychological Association New York","article-title":"An assessment of the behavioral effects of the endorphin system with instrumental and classical conditioning paradigms","author":"Erhman","year":"1979"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0023-9690(81)90002-3","article-title":"Naloxone and Pavlovian fear conditioning","volume":"12","author":"Fanselow","year":"1981","journal-title":"Learn Motiv"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0065","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0196-9781(91)90056-U","article-title":"Differential effects of selective opioid peptide antagonists on the acquisition of pavlovian fear conditioning","volume":"12","author":"Fanselow","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nlm.2005.03.001","article-title":"Deletion of the mu opioid receptor results in impaired acquisition of Pavlovian context fear","volume":"84","author":"Sanders","year":"2005","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0075","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1037\/0735-7044.117.6.1292","article-title":"Opioid receptors regulate the extinction of Pavlovian fear conditioning","volume":"117","author":"McNally","year":"2003","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1037\/0735-7044.118.1.111","article-title":"Blocking, unblocking, and overexpectation of fear: a role for opioid receptors in the regulation of Pavlovian association formation","volume":"118","author":"McNally","year":"2004","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0085","series-title":"A Theory of Pavlovian Conditioning: Variations in the Effectiveness of Reinforcement and Nonreinforcement","author":"Rescorla","year":"1972"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/14640747908400743","article-title":"One-Trial Overshadowing","volume":"31","author":"Mackintosh","year":"1979","journal-title":"Q J Exp Psychol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0095","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1037\/a0020083","article-title":"Opioid regulation of Pavlovian overshadowing in fear conditioning","volume":"124","author":"Zelikowsky","year":"2010","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0100","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1523\/JNEUROSCI.1828-04.2004","article-title":"Opioid receptors in the midbrain periaqueductal gray regulate extinction of pavlovian fear conditioning","volume":"24","author":"McNally","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0166-4328(93)90088-8","article-title":"The periaqueductal gray and defensive behavior: functional representation and neuronal organization","volume":"58","author":"Carrive","year":"1993","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0110","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1037\/0735-7044.119.4.1023","article-title":"The midbrain periaqueductal gray and fear extinction: opioid receptor subtype and roles of cyclic AMP, protein kinase A, and mitogen-activated protein kinase","volume":"119","author":"McNally","year":"2005","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0115","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1037\/0735-7044.119.6.1672","article-title":"Facilitation of fear extinction by midbrain periaqueductal gray infusions of RB101(S), an inhibitor of enkephalin-degrading enzymes","volume":"119","author":"McNally","year":"2005","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1037\/0022-006X.56.2.287","article-title":"Endogenous opiate system and systematic desensitization","volume":"56","author":"Egan","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0125","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1037\/0022-006X.61.5.865","article-title":"Opioid antagonist affects behavioral effects of exposure in vivo","volume":"61","author":"Arntz","year":"1993","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1101\/lm.403607","article-title":"Orphanin FQ\/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation","volume":"14","author":"Roozendaal","year":"2007","journal-title":"Learn Mem"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/29073","article-title":"Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors","volume":"394","author":"Manabe","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0145","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1460-9568.2002.01926.x","article-title":"A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory","volume":"15","author":"Higgins","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1037\/0735-7044.122.1.98","article-title":"Effects of nociceptin\/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats","volume":"122","author":"Fornari","year":"2008","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0155","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biopsych.2011.03.017","article-title":"Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats","volume":"70","author":"Knoll","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0165","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/257604a0","article-title":"New peptide in the vertebrate CNS reacting with antigastrin antibodies","volume":"257","author":"Vanderhaeghen","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1985.tb07105.x","article-title":"Neuronal cholecystokinin: one or multiple transmitters?","volume":"44","author":"Rehfeld","year":"1985","journal-title":"J Neurochem"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0091-3057(94)90467-7","article-title":"Heterogeneity of CCK-B receptors involved in animal models of anxiety","volume":"49","author":"Derrien","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0180","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.07-09-02967.1987","article-title":"Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists","volume":"7","author":"Hill","year":"1987","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2004.01.045","article-title":"Immunolocalization of CCK1R in rat brain using a new anti-peptide antibody","volume":"359","author":"Mercer","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(89)90290-2","article-title":"A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260","volume":"162","author":"Lotti","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0195","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1471-4159.1994.62041426.x","article-title":"Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors","volume":"62","author":"Schafer","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002210050546","article-title":"Major biological actions of CCK\u2013a critical evaluation of research findings","volume":"123","author":"Fink","year":"1998","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(84)90111-0","article-title":"Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats","volume":"98","author":"Fekete","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0210","first-page":"269","article-title":"Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide","volume":"58","author":"Kadar","year":"1981","journal-title":"Acta Physiol Acad Sci Hung"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0215","first-page":"83","article-title":"Cholecystokinin and learning and memory processes","volume":"27","author":"Hadjiivanova","year":"2003","journal-title":"Acta Physiol Pharmacol Bulg"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0220","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neubiorev.2005.05.008","article-title":"Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats","volume":"29","author":"Wang","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0225","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","article-title":"Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings","volume":"46","author":"de Montigny","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1994.03950060050005","article-title":"The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder","volume":"51","author":"Bradwejn","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0240","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.1990.01810160095016","article-title":"Cholecystokinin-4 and panic","volume":"47","author":"Abelson","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0245","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1176\/ajp.152.8.1180","article-title":"Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers","volume":"152","author":"Benkelfat","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0250","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0006-3223(98)00348-5","article-title":"Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points","volume":"45","author":"Javanmard","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0255","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.mp.4000507","article-title":"Investigation of cholecystokinin system genes in panic disorder","volume":"4","author":"Kennedy","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0265","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopsych.2010.10.010","article-title":"Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways","volume":"69","author":"Muinos-Gimeno","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0270","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00001756-199510010-00030","article-title":"Cholecystokinin enhances the acoustic startle response in rats","volume":"6","author":"Fendt","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0275","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.02-06-00791.1982","article-title":"A primary acoustic startle circuit: lesion and stimulation studies","volume":"2","author":"Davis","year":"1982","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0280","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0196-9781(95)02013-M","article-title":"The CCKB antagonist, L-365,260, attenuates fear-potentiated startle","volume":"16","author":"Josselyn","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(96)00756-1","article-title":"Intracerebroventricular infusion of the CCKB receptor agonist pentagastrin potentiates acoustic startle","volume":"733","author":"Frankland","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0290","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.17-05-01838.1997","article-title":"Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat","volume":"17","author":"Frankland","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0295","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/npp.2008.97","article-title":"Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning","volume":"34","author":"Chhatwal","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0300","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-8993(03)02625-8","article-title":"Immunohistochemical characterization of cholecystokinin containing neurons in the rat basolateral amygdala","volume":"976","author":"Mascagni","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-002-1181-4","article-title":"Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior","volume":"164","author":"Wunderlich","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0166-4328(90)90121-T","article-title":"Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics","volume":"39","author":"Harro","year":"1990","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF00168543","article-title":"Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein","volume":"348","author":"Vasar","year":"1993","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0325","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0924-977X(97)00034-5","article-title":"Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels","volume":"7","author":"Koks","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(95)00859-4","article-title":"Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats","volume":"300","author":"Izumi","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0335","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1054\/npep.1999.0766","article-title":"Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158","volume":"33","author":"Tsutsumi","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0340","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-2001-18030","article-title":"Suppression of conditioned fear by administration of CCKB receptor antisense oligodeoxynucleotide into the lateral ventricle","volume":"34","author":"Tsutsumi","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0345","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-005-2255-x","article-title":"Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light\u2013dark exploration, but not in fear conditioning test","volume":"181","author":"Raud","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0350","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.0505407103","article-title":"Elevated cholecystokininergic tone constitutes an important molecular\/neuronal mechanism for the expression of anxiety in the mouse","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0355","doi-asserted-by":"crossref","first-page":"e15999","DOI":"10.1371\/journal.pone.0015999","article-title":"Bi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouse","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0360","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y\u2013a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0365","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.6136091","article-title":"Neuropeptide Y distribution in the rat brain","volume":"221","author":"Allen","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0370","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/306584a0","article-title":"Neuropeptide Y distribution in human brain","volume":"306","author":"Adrian","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0375","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0306-4522(85)90260-X","article-title":"The anatomy of neuropeptide-Y-containing neurons in rat brain","volume":"15","author":"Chronwall","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0380","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cne.902900305","article-title":"Neuronal localisation of neuropeptide Y gene expression in rat brain","volume":"290","author":"Morris","year":"1989","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0385","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1098\/rstb.2006.1855","article-title":"Neuropeptide Y in normal eating and in genetic and dietary-induced obesity","volume":"361","author":"Beck","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0390","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nm1611","article-title":"Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome","volume":"13","author":"Kuo","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0395","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0006-8993(89)91112-8","article-title":"Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic\/adrenergic neurotransmission","volume":"498","author":"Haas","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0400","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2826.1995.tb00757.x","article-title":"Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis","volume":"7","author":"Hanson","year":"1995","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0405","first-page":"R1523","article-title":"Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats","volume":"266","author":"White","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0410","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1471-4159.1999.0730641.x","article-title":"Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices","volume":"73","author":"King","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0415","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1523\/JNEUROSCI.17-13-05175.1997","article-title":"Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression","volume":"17","author":"Pomonis","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0420","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0196-9781(01)00356-4","article-title":"Neuropeptide Y in the mammalian circadian system: effects on light-induced circadian responses","volume":"22","author":"Yannielli","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0425","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2004.04.006","article-title":"Neuropeptide Y and epilepsy: recent progress, prospects and controversies","volume":"38","author":"Baraban","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0430","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.npep.2004.04.005","article-title":"A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse","volume":"38","author":"Thiele","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0435","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.peptides.2004.03.001","article-title":"NPY\u2013an endearing journey in search of a neurochemical on\/off switch for appetite, sex and reproduction","volume":"25","author":"Kalra","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0440","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pupt.2004.04.003","article-title":"Neuropeptide Y (NPY)","volume":"17","author":"Groneberg","year":"2004","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0445","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/1568007054546153","article-title":"The putative neuroprotective role of neuropeptide Y in the central nervous system","volume":"4","author":"Silva","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0450","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0455","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pa.33.040193.001521","article-title":"Neuropeptide Y-related peptides and their receptors\u2013are the receptors potential therapeutic drug targets?","volume":"33","author":"Wahlestedt","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0460","first-page":"R192","article-title":"Regulation of NPY\/NPY Y1 receptor\/G protein system in rat brain cortex","volume":"268","author":"Michel","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0465","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.nut.2008.06.025","article-title":"Molecular recognition of the NPY hormone family by their receptors","volume":"24","author":"Lindner","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0470","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1523\/JNEUROSCI.13-01-00073.1993","article-title":"Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain","volume":"13","author":"Dumont","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0475","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0361-9230(90)90084-D","article-title":"Mapping of neuropeptide Y-like immunoreactivity in the human forebrain","volume":"24","author":"Walter","year":"1990","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0480","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0891-0618(00)00107-1","article-title":"Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum","volume":"20","author":"Caberlotto","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0485","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","article-title":"Regional distribution of Y-receptor subtype mRNAs in rat brain","volume":"11","author":"Parker","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0490","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cne.10823","article-title":"Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry","volume":"464","author":"Wolak","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0495","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/cne.22143","article-title":"Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala","volume":"517","author":"Rostkowski","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0500","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(89)91706-X","article-title":"Modulation of memory processing by neuropeptide Y varies with brain injection site","volume":"503","author":"Flood","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0505","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0167-0115(92)90514-U","article-title":"Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test","volume":"41","author":"Heilig","year":"1992","journal-title":"Regul Pept"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0510","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-0115(95)00103-I","article-title":"Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding","volume":"59","author":"Heilig","year":"1995","journal-title":"Regul Pept"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0515","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-199504000-00001","article-title":"Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures","volume":"6","author":"Broqua","year":"1995","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0520","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s002130050313","article-title":"Anxiolytic activity of NPY receptor agonists in the conflict test","volume":"132","author":"Britton","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0525","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(99)00018-7","article-title":"Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test","volume":"368","author":"Sajdyk","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0530","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2005.02.038","article-title":"Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats","volume":"1043","author":"Kokare","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0535","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0540","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0278-5846(99)00029-9","article-title":"Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats","volume":"23","author":"Kask","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0545","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3565(25)12029-6","article-title":"Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226","volume":"275","author":"Wieland","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0550","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.npp.1300705","article-title":"Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors","volume":"30","author":"Primeaux","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0555","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0028-3908(02)00234-4","article-title":"Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats","volume":"43","author":"Sajdyk","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0560","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(01)00679-7","article-title":"Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala","volume":"71","author":"Sajdyk","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0565","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1523\/JNEUROSCI.0659-07.2008","article-title":"Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia","volume":"28","author":"Sajdyk","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0570","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1097\/00001756-199909290-00024","article-title":"Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress","volume":"10","author":"Thorsell","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0575","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1073\/pnas.220232997","article-title":"Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression","volume":"97","author":"Thorsell","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnbeh.2011.00054","article-title":"Differential Regulation of Neuropeptide Y in the Amygdala and Prefrontal Cortex during Recovery from Chronic Variable Stress","volume":"5","author":"McGuire","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0585","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-3565(25)38954-8","article-title":"Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice","volume":"268","author":"Nakajima","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0590","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/JMN:22:3:159","article-title":"Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing","volume":"22","author":"Redrobe","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0595","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(89)90659-9","article-title":"Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala","volume":"100","author":"McDonald","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0600","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.regpep.2004.03.011","article-title":"Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue","volume":"120","author":"Tovote","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0605","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.pbb.2004.12.009","article-title":"Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL\/6J mice","volume":"80","author":"Karlsson","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0610","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1523\/JNEUROSCI.2305-08.2008","article-title":"The role of neuropeptide Y in the expression and extinction of fear-potentiated startle","volume":"28","author":"Gutman","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0615","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1054\/npep.2000.0804","article-title":"Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone","volume":"34","author":"Krysiak","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0620","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.neuroscience.2009.09.079","article-title":"Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear","volume":"164","author":"Pickens","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0625","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-009-1610-8","article-title":"Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect","volume":"206","author":"Fendt","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0630","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2210-11-S2-A3","article-title":"Reduced fear conditioning after viral vector mediated neuropeptide Y administration into the basolateral amygdala","volume":"11","author":"Verma","year":"2011","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0635","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3956(03)00101-8","article-title":"Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism","volume":"38","author":"Heilig","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0640","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0006-3223(99)00185-7","article-title":"Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD","volume":"47","author":"Rasmusson","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0645","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archgenpsychiatry.2010.197","article-title":"Emotion processing, major depression, and functional genetic variation of neuropeptide Y","volume":"68","author":"Mickey","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0650","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0006-3223(99)00239-5","article-title":"Plasma neuropeptide-Y concentrations in humans exposed to military survival training","volume":"47","author":"Morgan","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0655","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biopsych.2005.08.027","article-title":"Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping","volume":"59","author":"Yehuda","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0660","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0665","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats","volume":"22","author":"Walker","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.004_bb0670","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiatry"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938412000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938412000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T19:13:29Z","timestamp":1742670809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938412000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0031938412000972"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2012.03.004","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}